Mark Lackner
4Patents
1h-index
13Co-inventors
41Inventor score
Filing activity: Mar 12, 2009 → Jan 4, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9632091B2 | Compositions and methods for prostate cancer analysis | Physics | 1 | Active |
| US11440969B2 | Use of human epididymis protein 4 (HE4) for assessing responsiveness of MUC 16-positive cancer treatment | Chemistry; Metallurgy | 1 | Active |
| US11021711B2 | Genetic variations associated with drug resistance | Chemistry; Metallurgy | 0 | Active |
| US9879267B2 | Genetic variations associated with drug resistance | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.